GL1X · GenesisL1 explorer

Ligand · VX9

VX9 · 4-[[(2~{S},4~{a}~{R},6~{S},8~{a}~{S})-6-[(4~{S},5~{R})-4-[(2~{S})-butan-2-yl]-5,9-dimethyl-decyl]-4~{a}-methyl-2,3,4,5,6,7,8,8~{a}-octahydro-1~{H}-naphthalen-2-yl]oxy]-4-oxidanylidene-butanoic acid

VX9, 4-[[(2~{S},4~{a}~{R},6~{S},8~{a}~{S})-6-[(4~{S},5~{R})-4-[(2~{S})-butan-2-yl]-5,9-dimethyl-decyl]-4~{a}-methyl-2,3,4,5,6,7,8,8~{a}-octahydro-1~{H}-naphthalen-2-yl]oxy]-4-oxidanylidene-butanoic acid (C31 H56 O4, 492.8 g/mol), in the…

Component
VX9
Formula
C31 H56 O4
Class
ligand
Structures
1
PDB entries
1

Binding sites

VX9 in 1 structure; the first of them:

  • 8INZ · Cryo-EM structure of human HCN3 channel in apo state · VX9 C801 · binds ILE231, TRP234, GLU235, PHE238, TYR242, LEU244, VAL249

Residues it binds most

GLU 4, ILE 4, LEU 4, PHE 4, TRP 4, TYR 4, VAL 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.